205 related articles for article (PubMed ID: 9702917)
1. Dexamethasone-induced abnormalities in growth and bone metabolism in piglets are partially attenuated by growth hormone with no synergistic effect of insulin-like growth factor-I.
Ward WE; Donovan SM; Atkinson SA
Pediatr Res; 1998 Aug; 44(2):215-21. PubMed ID: 9702917
[TBL] [Abstract][Full Text] [Related]
2. Metabolic hormones modulate the effect of growth hormone (GH) on insulin-like growth factor-I (IGF-I) mRNA level in primary culture of salmon hepatocytes.
Pierce AL; Fukada H; Dickhoff WW
J Endocrinol; 2005 Feb; 184(2):341-9. PubMed ID: 15684342
[TBL] [Abstract][Full Text] [Related]
3. Coordinated regulation of the GH/IGF system genes during refeeding in rainbow trout (Oncorhynchus mykiss).
Gabillard JC; Kamangar BB; Montserrat N
J Endocrinol; 2006 Oct; 191(1):15-24. PubMed ID: 17065385
[TBL] [Abstract][Full Text] [Related]
4. The somatostatin subtype-2 receptor antagonist, BIM-23627, improves the catabolic effects induced by long-term glucocorticoid treatment in the rat.
Tulipano G; Rossi E; Culler MD; Taylor JE; Bonadonna S; Locatelli V; Cocchi D; Giustina A
Regul Pept; 2005 Feb; 125(1-3):85-92. PubMed ID: 15582718
[TBL] [Abstract][Full Text] [Related]
5. Growth hormone (GH) stimulates insulin-like growth factor-I (IGF-I) and IGF-binding protein (IGFBP)-2 gene expression in spleens of juvenile rats.
Yakar S; Domene H; Meidan R; Cassorla F; Gilad I; Koch I; Laron Z; Roberts CT; LeRoith D; Eshet R
Horm Metab Res; 1994 Aug; 26(8):363-6. PubMed ID: 7528707
[TBL] [Abstract][Full Text] [Related]
6. Organ-specific effects and interactions of acute insulin-like growth factor I (IGF-I) and growth hormone (GH).
Pascual M; Larralde J; Martínez JA
Growth Dev Aging; 1995; 59(4):181-91. PubMed ID: 8770610
[TBL] [Abstract][Full Text] [Related]
7. Serum levels of insulin-like growth factor binding proteins (IGFBP)-4 and -5 correlate with bone mineral density in growth hormone (GH)-deficient adults and increase with GH replacement therapy.
Thorén M; Hilding A; Brismar T; Magnusson P; Degerblad M; Larsson L; Sääf M; Baylink DJ; Mohan S
J Bone Miner Res; 1998 May; 13(5):891-9. PubMed ID: 9610754
[TBL] [Abstract][Full Text] [Related]
8. Effects of growth hormone and insulin-like growth factor-I singly and in combination on in vivo capacity of urea synthesis, gene expression of urea cycle enzymes, and organ nitrogen contents in rats.
Grøfte T; Wolthers T; Jensen SA; Møller N; Jørgensen JO; Tygstrup N; Orskov H; Vilstrup H
Hepatology; 1997 Apr; 25(4):964-9. PubMed ID: 9096605
[TBL] [Abstract][Full Text] [Related]
9. Bone metabolism and circulating IGF-I and IGFBPs in dexamethasone-treated preterm infants.
Ward WE; Atkinson SA; Donovan SM; Paes B
Early Hum Dev; 1999 Dec; 56(2-3):127-41. PubMed ID: 10636592
[TBL] [Abstract][Full Text] [Related]
10. Secretion of insulin-like growth factor (IGF)-I and -II and IGF binding proteins (IGFBPs) in fetal stromal-vascular (S-V) cell cultures obtained before and after the onset of adipogenesis in vivo.
Hausman GJ; Richardson RL; Simmen FA
Growth Dev Aging; 2002; 66(1):11-26. PubMed ID: 12212627
[TBL] [Abstract][Full Text] [Related]
11. Effect of dietary energy and somatotropin on components of the somatotropic axis in Holstein heifers.
Radcliff RP; VandeHaar MJ; Kobayashi Y; Sharma BK; Tucker HA; Lucy MC
J Dairy Sci; 2004 May; 87(5):1229-35. PubMed ID: 15290971
[TBL] [Abstract][Full Text] [Related]
12. Free dissociable insulin-like growth factor I (IGF-I), total IGF-I and their binding proteins in girls with Turner syndrome during long-term growth hormone treatment.
Bannink EM; van Doorn J; Stijnen T; Drop SL; de Muinck Keizer-Schrama SM
Clin Endocrinol (Oxf); 2006 Sep; 65(3):310-9. PubMed ID: 16918949
[TBL] [Abstract][Full Text] [Related]
13. Low dose recombinant human growth hormone normalizes bone metabolism and cortical bone density and improves trabecular bone density in growth hormone deficient adults without causing adverse effects.
Amato G; Izzo G; La Montagna G; Bellastella A
Clin Endocrinol (Oxf); 1996 Jul; 45(1):27-32. PubMed ID: 8796135
[TBL] [Abstract][Full Text] [Related]
14. Effects of recombinant human growth hormone and insulin-like growth factor-I, with or without 17 beta-estradiol, on bone and mineral homeostasis of aged ovariectomized rats.
Verhaeghe J; van Bree R; Van Herck E; Thomas H; Skottner A; Dequeker J; Mosekilde L; Einhorn TA; Bouillon R
J Bone Miner Res; 1996 Nov; 11(11):1723-35. PubMed ID: 8915780
[TBL] [Abstract][Full Text] [Related]
15. Dexamethasone administration attenuates the inhibitory effect of lipopolysaccharide on IGF-I and IGF-binding protein-3 in adult rats.
Priego T; Granado M; Martín AI; López-Calderón A; Villanúa MA
J Endocrinol; 2005 Jun; 185(3):467-76. PubMed ID: 15930173
[TBL] [Abstract][Full Text] [Related]
16. Liver-specific overexpression of the insulin-like growth factor-I enhances somatic growth and partially prevents the effects of growth hormone deficiency.
Liao L; Dearth RK; Zhou S; Britton OL; Lee AV; Xu J
Endocrinology; 2006 Aug; 147(8):3877-88. PubMed ID: 16709615
[TBL] [Abstract][Full Text] [Related]
17. Short-term effects of growth hormone and insulin-like growth factor I on cancellous bone in rhesus macaque monkeys.
Sass DA; Jerome CP; Bowman AR; Bennett-Cain A; Ginn TA; LeRoith D; Epstein S
J Clin Endocrinol Metab; 1997 Apr; 82(4):1202-9. PubMed ID: 9100597
[TBL] [Abstract][Full Text] [Related]
18. Comparative response in growth and bone status to three dexamethasone treatment regimens in infant piglets.
Guo CY; Ward W; Cairns P; Atkinson S
Pediatr Res; 2000 Aug; 48(2):238-43. PubMed ID: 10926301
[TBL] [Abstract][Full Text] [Related]
19. Insulin-like growth factor-I but not growth hormone attenuates dexamethasone-induced catabolism in parenterally fed rats.
Lo HC; Hinton PS; Yang H; Unterman TG; Ney DM
JPEN J Parenter Enteral Nutr; 1996; 20(3):171-7. PubMed ID: 8776688
[TBL] [Abstract][Full Text] [Related]
20. Regulation of components of the ubiquitin system by insulin-like growth factor I and growth hormone in skeletal muscle of rats made catabolic with dexamethasone.
Chrysis D; Underwood LE
Endocrinology; 1999 Dec; 140(12):5635-41. PubMed ID: 10579327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
